Eli Lilly and Co (LLY)
795.08
-1.20
(-0.15%)
USD |
NYSE |
Dec 24, 13:00
795.70
+0.62
(+0.08%)
After-Hours: 13:49
Eli Lilly Research and Development Expense (Quarterly): 2.734B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen Inc | 1.45B |
| Biogen Inc | 542.70M |
| Regeneron Pharmaceuticals Inc | 1.272B |
| Viking Therapeutics Inc | 22.78M |
| Moderna Inc | 1.137B |